Literature DB >> 8406515

Orosomucoid polymorphism in Finns, Swedes and Swedish Saamis.

C Fan1, C Sikström, G Beckman, L Beckman.   

Abstract

Genetic polymorphism of orosomucoid (ORM) was studied by isoelectric focusing and immunoblotting in Finns, Swedes and Swedish Saamis. The ORM2 locus was found to be monomorphic in all three ethnic groups. In the Swedish sample the frequency of the ORM1*2 allele (0.414) was within the range found in other European populations, whereas Finns (0.282) and Saamis (0.210) showed significantly lower ORM1*2 frequencies. The extremely low ORM1*2 frequency in the Saamis further underlines the genetic uniqueness of this population. The ORM1*2 frequency in Saamis resembles those in Asiatic Mongoloid populations, but this is unlikely to reflect an Asiatic influence, since the accumulated knowledge on genetic markers in the Saamis show no unequivocal evidence for an Asiatic influence in this population.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406515     DOI: 10.1159/000154144

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  4 in total

Review 1.  Lifestyle, genetics, and disease in Sami.

Authors:  Alastair B Ross; Asa Johansson; Max Ingman; Ulf Gyllensten
Journal:  Croat Med J       Date:  2006-08       Impact factor: 1.351

2.  Evaluation of the SNP tagging approach in an independent population sample--array-based SNP discovery in Sami.

Authors:  Asa Johansson; Veronika Vavruch-Nilsson; David R Cox; Kelly A Frazer; Ulf Gyllensten
Journal:  Hum Genet       Date:  2007-06-07       Impact factor: 4.132

3.  Cancer risk in the reindeer breeding Saami population of Sweden, 1961-1997.

Authors:  S Hassle; P Sjölander; M Barnekow-Bergkvist; A Kadesjö
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

4.  Cancer in the Sami population of Sweden in relation to lifestyle and genetic factors.

Authors:  Sven Hassler; Per Sjölander; Henrik Grönberg; Robert Johansson; Lena Damber
Journal:  Eur J Epidemiol       Date:  2008-03-06       Impact factor: 8.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.